Why this East Bay drug maker plans to add 300 jobs
October 30, 2018 at 17:09 PM EDT
With some $25.5 million in state tax credits, this Germany-based company is expanding its Fremont site to handle its own so-called "biosimilars" as well as contract work from Bay Area biotech companies.
